Aging Program Project Grant 6

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

May 31, 2024

Study Completion Date

May 31, 2024

Conditions
Improving Cardiometabolic Outcomes in Older Adults
Interventions
DIETARY_SUPPLEMENT

Melatonin 1 mg

Melatonin (1mg) will be administered daily during the intervention. Melatonin capsules will be obtained from Life Extension (Ft. Lauderdale, FL). The investigational drug pharmacy (IDP) at Northwestern Memorial Hospital will encapsulate the melatonin pills so the placebo (lactose) and melatonin pills appear identical. We have worked with this IDP on other projects. The investigators on this study have experience in administering melatonin for investigational and clinical purposes.

DIETARY_SUPPLEMENT

Placebos

Placebo will be administered daily during the intervention. The investigational drug pharmacy (IDP) at Northwestern Memorial Hospital will encapsulate the pills so the placebo (lactose/starch) and melatonin pills appear identical. We have worked with this IDP on other projects. The investigators on this study have experience in administering melatonin for investigational and clinical purposes.

OTHER

Meal timing

Subjects are instructed to maintain an extended overnight fasting period of 12-16 hours.

OTHER

Non-Meal timing

Subjects are instructed to maintain their habitual meal timing.

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
lead

Northwestern University

OTHER

NCT03490825 - Aging Program Project Grant 6 | Biotech Hunter | Biotech Hunter